Watch CBS News

Vaccine

cbsn-fusion-only-4-of-all-covid-vaccine-doses-administered-in-us-went-to-long-term-care-facility-residents-thumbnail-642468-640x360.jpg

Slow COVID vaccine rollout for senior homes

As millions of Americans get vaccinated against the coronavirus nationwide, one vulnerable population has been largely underserved. CBS News spoke to the executive director of a long-term care facility for seniors in Northern California, which lost 13 of its residents at the beginning of the pandemic. She says getting her residents vaccinated has been challenging and says she has not received any help from the federal vaccination program. Jonathan Vigliotti reports.

pfizervariant-642563-640x360.jpg

Top Pfizer scientist on COVID-19 vaccine

Pfizer announced it will supply 200 million doses of its COVID-19 vaccine for the U.S. by the end of May and is aiming to ship 2 billion doses globally this year. The vaccine is over 90% effective according to clinical trials conducted in 2020, but more testing needs to be done to see how well it protects against the new variants. Dr. Phil Dormitzer, who helped develop the vaccine as vice president and chief scientific officer of viral vaccines at Pfizer, joins CBSN to discuss.

cbsn-fusion-health-experts-urge-caution-as-us-infections-and-hospitalizations-decline-thumbnail-642363-640x360.jpg

COVID cases and hospitalizations decline in U.S.

The fight against the coronavirus is gaining momentum in the U.S. as hospitalizations and infections continue to fall. As CBS News' Meg Oliver reports, health experts warn the U.S. not out of the woods yet as variants emerge and the Super Bowl threatens to be the next super-spreader event. Dr. Dara Kass, an ER doctor and medical contributor for Yahoo News, joins CBSN's Elaine Quijano with the latest developments on the pandemic.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue